@article{JTD21464,
author = {Mahmoud Ismail and Dania Nachira and Elisa Meacci and Gian Maria Ferretti and Marc Swierzy and Julianna Paulina Englisch and Ramin Raul Ossami Saidy and Svea Faber and Maria Teresa Congedo and Marco Chiappetta and Leonardo Petracca Ciavarella and Stefano Margaritora and Jens C. Rueckert},
title = {Uniportal video-assisted thoracic surgery in the treatment of pleural empyema},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 31},
year = {2018},
keywords = {},
abstract = {Background: The efficacy of video-assisted thoracic surgery (VATS) in the treatment of pleural empyema has recently been proven. Till today, very few works evaluated the role of uniportal-VATS (U-VATS) approach in the treatment of pleural empyema even if it currently represents the most innovative and less invasive thoracoscopic approach. We report our experience with U-VATS in the treatment of pleural empyema.
Methods: A retrospective bicentric analysis of 35 consecutive patients who underwent surgical treatment of stage II and stage III pleural empyema was performed, from January 2015 to May 2017.
Results: The mean age of patients was 57.26±18.29 years and 54.3% of them were males. In 85.7% of the cases, empyema was related to a complicated parapneumonic effusion; in only 5 cases it was a post-surgical consequence. All patients were treated with broad-spectrum antibiotics and subsequent target therapy for 14.62±21.76 days prior to operation and 23 patients needed the placement of a chest tube. Twenty patients (57.1%) presented with stage III, 11 patients (31.4%) stage II and 4 patients (11.4%) stage I empyema. Complete debridement and decortication were obtained in all patients through U-VATS approach and no conversion or further access was needed for any reason. No major complication was recorded. Only 2 cases of trapped lung were not responsive to surgical treatment. At a mean follow-up of 247.42±306.29 days, 33 patients (94.3%) were alive with no recurrence, 2 patients died for causes unrelated to the operation.
Conclusions: According to our experience, we consider U-VATS as an adequate procedure in the treatment of “stages II and III” empyemas when the necessary surgical expertise has been achieved. Indeed, U-VATS permits an easier performance and complete debridement and decortication, with a very low risk for conversion and excellent postoperative outcomes in terms of less pain, fast recovery and cosmetic results.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/21464}
}